Ciclesonide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ciclesonide. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Headache | 6% |
| Epistaxis | 4.9% |
| Nasopharyngitis | 3.7% |
| Pharyngolaryngeal pain | 3.4% |
| Ear pain | 2.2% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Seasonal Allergic RhinitisOMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older. Perennial Allergic RhinitisOMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with perennial allergic rhinitis in adults and adolescents 12 years of age and older.
Source: FDA labeling via NIH DailyMed (set 45e1c9d9…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.